Lentiviral Vector Platform for Production of Bioengineered Recombinant Coagulation Factor VIII

Patients with hemophilia A present with spontaneous and sometimes life-threatening bleeding episodes that are treated using blood coagulation factor VIII (fVIII) replacement products. Although effective, these products have limited availability worldwide due to supply limitations and product costs,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Spencer, H Trent, Denning, Gabriela, Gautney, Richard E, Dropulic, Boro, Roy, Andre J, Baranyi, Lajos, Gangadharan, Bagirath, Parker, Ernest T, Lollar, Pete, Doering, Christopher B
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3034847/
https://ncbi.nlm.nih.gov/pubmed/21081907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.239
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados